Camurus AB header image

Camurus AB

CAMX

Equity

ISIN SE0007692850 / Valor 30510553

NASDAQ Nordic Exchange Stockholm, Equities (2026-10-09)

SEK 641.00+1.75%

Camurus AB
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Camurus AB is a Swedish specialty pharmaceutical company that develops and commercializes long‑acting injectable medicines based on its proprietary FluidCrystal lipid‑based drug delivery technology, which is designed to provide sustained subcutaneous release of peptides and small molecules. Its most advanced commercial product is Buvidal (buprenorphine), a weekly and monthly injectable treatment for opioid use disorder that is marketed in multiple countries, and the company pursues a pipeline of clinical‑stage programs and partnered projects targeting pain, oncology and rare diseases. Camurus combines in‑house development with collaborations and regulatory filings to advance formulations that aim to improve dosing frequency and patient adherence, and it is listed on the Nasdaq Stockholm exchange.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-7.90%1Y

110%3Y

291%5Y

Performance

49.5%1Y

45.7%3Y

43.8%5Y

Volatility

3815 M

Market cap (USD)

96,270

Daily traded volume (Shares)

581.5 / 567

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

0.69%SEK 263.70

CVS Group PLC

CVS Group PLC Valor: 3457960

Annual Return

-50%0%+50%

Risk level

110

2.45%GBP 11.73

Tilray Brands Inc

Tilray Brands Inc Valor: 42386407

Annual Return

-50%0%+50%

Risk level

110

-1.39%USD 3.54

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

0.08%INR 801.05

Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Ltd. Valor: 30795490

Annual Return

-50%0%+50%

Risk level

110

1.69%INR 1,719.55

Summit Therapeutics Inc

Summit Therapeutics Inc Valor: 56903013

Annual Return

-50%0%+50%

Risk level

110

2.45%USD 17.59

Abbott Laboratories

Abbott Laboratories Valor: 903037

Annual Return

-50%0%+50%

Risk level

110

1.13%USD 99.60

Sienna Senior Living Inc

Sienna Senior Living Inc Valor: 28093100

Annual Return

-50%0%+50%

Risk level

110

-0.36%CAD 19.29

Demant A/S

Demant A/S Valor: 32651962

Annual Return

-50%0%+50%

Risk level

110

6.16%DKK 341.20

MedNation AG

MedNation AG Valor: 331107

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 4.00

SIX

FactSet

Clearbit

Logos provided by Clearbit